|
Re: Farxiga (SGLT2i) approved for CKD patients with AND without T2D
|
1
|
Resverlogix Corp.
|
May 03, 2021 07:11AM
|
|
Re: Farxiga (SGLT2i) approved for CKD patients with AND without T2D
|
2
|
Resverlogix Corp.
|
May 02, 2021 09:44PM
|
|
Re: FDA meeting
|
3
|
Resverlogix Corp.
|
Aug 09, 2022 08:50AM
|
|
Re: FDA meeting
|
3
|
Resverlogix Corp.
|
Aug 09, 2022 01:22PM
|
|
Re: FDA meeting
|
4
|
Resverlogix Corp.
|
Aug 09, 2022 03:31PM
|
|
Re: Feb. 06, 2019 FMV ZENE!
|
2
|
Zenith Epigenetics
|
Feb 07, 2019 04:13PM
|
|
Re: Feb. 06, 2019 FMV ZENE!
|
2
|
Zenith Epigenetics
|
Feb 07, 2019 01:33PM
|
|
Re: Feb. 06, 2019 FMV ZENE!
|
2
|
Zenith Epigenetics
|
Feb 07, 2019 02:42PM
|
|
Re: Feb. 06, 2019 FMV ZENE!
|
1
|
Zenith Epigenetics
|
Feb 07, 2019 03:18PM
|
|
Re: Filled!
|
|
Zenith Epigenetics
|
Jan 22, 2021 03:39PM
|
|
Re: Finally some news
|
3
|
BIOASIS TECHNOLOGIES INC
|
Apr 17, 2022 03:45PM
|
|
Re: Finance
|
2
|
Resverlogix Corp.
|
Aug 07, 2020 05:02PM
|
|
Re: Finance
|
4
|
Resverlogix Corp.
|
May 26, 2020 09:37PM
|
|
Re: Finance
|
2
|
Resverlogix Corp.
|
May 27, 2020 09:13AM
|
|
Re: Finance
|
3
|
Resverlogix Corp.
|
Aug 10, 2020 08:37AM
|
|
Re: Finance
|
6
|
Resverlogix Corp.
|
Aug 07, 2020 08:42AM
|
|
Re: Finance
|
3
|
Resverlogix Corp.
|
Aug 12, 2020 04:03PM
|
|
Re: Financial Future
|
2
|
Resverlogix Corp.
|
May 19, 2019 07:51PM
|
|
Re: Financials and MD&A on SEDAR
|
1
|
BIOASIS TECHNOLOGIES INC
|
Jan 31, 2017 04:51PM
|
|
Re: Financing curiousity
|
4
|
Resverlogix Corp.
|
Jan 27, 2018 07:43AM
|
